“Eli Lilly has continued to show that they’re the dominant player in the space… but when the shares ultimately get hit, like they have today, it tends to be a buying opportunity”

VIEW Hims and Hers Health’s compounded Wegovy pill offering fuels market jitters

For investment professionals

The Investment Hub carries the full Aptus research library — manager research, market dashboards, models, and a studio that renders it all on your firm's letterhead.